Oscar Health, Inc. - COMMON STOCK (OSCR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
OSCR on NYSE
Shares outstanding
224,919,027
Price per share
$14.37
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
149,595,823
Total reported value
$2,831,901,620
% of total 13F portfolios
0.01%
Share change
-18,874,664
Value change
-$426,027,088
Number of holders
330
Price from insider filings
$14.37
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oscar Health, Inc. - COMMON STOCK (OSCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.4% $298,910,284 13,941,711 BlackRock, Inc. 30 Jun 2025
JPMORGAN CHASE & CO 4.5% -32% $143,092,346 -$55,508,727 9,950,789 -28% JPMORGAN CHASE & CO. 30 Jun 2025
T. Rowe Price Investment Management, Inc. 3.7% $157,535,536 8,322,004 T. Rowe Price Investment Management, Inc. 30 Sep 2025

As of 30 Sep 2025, 330 institutional investors reported holding 149,595,823 shares of Oscar Health, Inc. - COMMON STOCK (OSCR). This represents 67% of the company’s total 224,919,027 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Oscar Health, Inc. - COMMON STOCK (OSCR) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9% 20,160,399 +2.1% 0.01% $381,636,353
BlackRock, Inc. 7.2% 16,186,352 +2.7% 0.01% $306,407,651
T. Rowe Price Investment Management, Inc. 3.7% 8,307,496 -34% 0.1% $157,261,000
Thrive Capital Management, LLC 2.8% 6,343,617 0% 25% $120,084,670
AMERICAN CENTURY COMPANIES INC 2.4% 5,298,340 +89% 0.05% $100,297,576
STATE STREET CORP 2.3% 5,131,849 -5% 0% $97,145,902
MORGAN STANLEY 2.1% 4,770,288 +74% 0.01% $90,301,570
GEODE CAPITAL MANAGEMENT, LLC 2.1% 4,681,883 +3.9% 0.01% $88,641,210
CITADEL ADVISORS LLC 1.9% 4,287,208 +114% 0.07% $81,156,848
DIMENSIONAL FUND ADVISORS LP 1.7% 3,718,765 +0.86% 0.02% $70,399,629
FARALLON CAPITAL MANAGEMENT LLC 1.6% 3,639,000 +147% 0.39% $68,886,270
Capital World Investors 1.6% 3,622,586 0% 0.01% $68,575,553
PRICE T ROWE ASSOCIATES INC /MD/ 1.3% 2,999,618 +341% 0.01% $56,783,000
GLYNN CAPITAL MANAGEMENT LLC 1.3% 2,856,025 -5.1% 17% $54,064,553
UBS Group AG 1.1% 2,510,470 +155% 0.01% $47,523,197
JPMORGAN CHASE & CO 1.1% 2,476,645 -75% 0% $46,882,908
GOLDMAN SACHS GROUP INC 0.98% 2,211,242 +4.4% 0.01% $41,858,811
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.87% 1,948,418 -11% 0.05% $36,883,553
NORTHERN TRUST CORP 0.82% 1,835,394 +4% 0% $34,744,008
JANE STREET GROUP, LLC 0.79% 1,768,955 +493% 0.04% $33,486,318
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.76% 1,719,168 +4.6% 0.01% $32,543,850
TUDOR INVESTMENT CORP ET AL 0.74% 1,669,198 +180% 0.2% $31,597,918
D. E. Shaw & Co., Inc. 0.71% 1,586,859 +74% 0.02% $30,039,241
HRT FINANCIAL LP 0.68% 1,518,643 +180% 0.11% $28,747,000
STATE OF MICHIGAN RETIREMENT SYSTEM 0.64% 1,450,000 0.13% $27,448,500

Institutional Holders of Oscar Health, Inc. - COMMON STOCK (OSCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,227,006 $46,429,839 +$10,473,753 $14.37 25
2025 Q3 149,595,823 $2,831,901,620 -$426,027,088 $18.93 330
2025 Q2 168,548,889 $3,611,647,706 -$289,634,922 $21.44 323
2025 Q1 186,598,634 $2,446,656,406 -$110,044,429 $13.11 285
2024 Q4 194,956,941 $2,621,590,374 +$146,853,067 $13.44 257
2024 Q3 178,386,882 $3,782,103,219 +$110,762,194 $21.21 279
2024 Q2 172,745,011 $2,733,174,271 +$252,278,335 $15.82 258
2024 Q1 156,903,935 $2,334,180,594 +$193,138,229 $14.87 215
2023 Q4 150,724,824 $1,379,131,654 -$3,785,138 $9.15 186
2023 Q3 147,067,613 $819,530,306 -$7,326,284 $5.57 175
2023 Q2 148,010,019 $1,192,835,277 +$5,911,074 $8.06 161
2023 Q1 147,482,265 $964,531,497 +$66,794,321 $6.54 130
2022 Q4 139,544,348 $343,274,000 -$14,475,084 $2.46 129
2022 Q3 146,909,762 $733,091,997 +$22,710,896 $4.99 129
2022 Q2 142,413,972 $605,294,235 -$91,989,720 $4.25 126
2022 Q1 143,850,142 $1,434,295,239 +$18,060,433 $9.97 122
2021 Q4 130,976,699 $1,028,199,597 +$32,022,110 $7.85 107
2021 Q3 125,835,387 $2,183,281,915 -$105,326,121 $17.39 87
2021 Q2 128,494,559 $2,769,676,759 -$63,986,538 $21.50 75
2021 Q1 136,426,375 $3,646,678,745 +$3,332,048,743 $26.88 88